PALO ALTO, Calif., June 3 -- Nanosys Inc., a developer of nanotechnology-enabled systems, announced today it has raised $38 million in the second closing of its second-round financing, led by CDIB BioScience Ventures. Corporate strategic investors included Eastman Kodak Co. and H.B. Fuller. Participating in the second closing are UOB Hermes Asia Technology Fund and UOB Venture Technology Investments Ltd., managed by UOB Venture Management Pte Ltd., and Healthcare Focus Fund L.P., managed by Arch Venture Partners for the California Public Employees' Retirement System. The investors in the first closing included ARCH Venture Partners, CW Group, Polaris Venture Partners, Venrock Associates, Prospect Venture Partners, Alexandria Real Estate Equities, CDIB BioScience Ventures, Chiao Tung Bank, China Development Industrial Bank, Harris & Harris, Lux Capital, Quanta Computer and SAIC Venture Capital Corp.
"The Nanosys technology portfolio aligns well with Kodak's focus on investing in disruptive infoimaging technologies that merge information technology and image science," said James C. Stoffel, CTO director of research and development at Eastman Kodak. "Kodak researchers are continuously scanning the technology marketplace seeking innovate solutions that complement our core competences. Nanosys's macroelectronics technology enabled by semiconductor nanomaterials is a paradigm shift which has the potential to revolutionize a wide range of macroelectronics applications, such as flat-panel displays."
Stephen Empedocles, Nanosys's founder and director of business development, said the funding will help the company achieve its goal of "becoming the key supplier of nanotechnology-enabled systems through collaborations with leading strategic partners worldwide."
For more information, visit: www.nanosysinc.com